Bronze sponsorsWe are grateful to our Bronze sponsors for committing £ 2,500 towards this world Congress. The sponsorship monies will enable EB 2020 to be a truly ground-breaking industry event and to have longevity beyond the four days of Congress. We look forward to working with our sponsors. To find out more about becoming a sponsor please visit our sponsorship opportunities page to see the benefits of sponsoring EB 2020 for your company. Jenny Jackson, Sponsorship Lead would be delighted to talk about tailoring the packages for your company’s needs, please contact Jenny via firstname.lastname@example.org to discuss ways your company can get involved.
FarmaMondo SwitzerlandFarmaMondo SA (established 1915) is a Swiss-based pharmaceutical service provider facilitating ethical patient access to unmet medical needs via Global Early-Access and Named-Patient mechanisms. Our mission is to facilitate patient access for unmet medical needs in an ethical way. Established in 1915, FarmaMondo boast over 100 years of track record services to its pharmaceutical and biotech partners. Throughout its history, FarmaMondo has always strived to satisfy unmet medical needs where they exist, enduring the test of time by operating in a sustainable and responsible manner as per Swiss business ethics. As medical needs and relevant regulations evolve, so has FarmaMondo. We are now regarded as one of the preferred service providers in the world of unlicensed medicines by manufacturers, regulators and healthcare professionals alike.
Urgo MedicalBecause wounds are a source of suffering, our mission as “the Healing Company” is to support healthcare professionals every day in delivering evidence-based treatments from the beginning so that life can start again for patients. At Urgo Medical, we strongly believe that we can make a difference by:
- Putting patients at the heart. We give a voice to patients so we can understand their needs and adapt our solutions to better meet them.
- Being the professional’s partner. We work closely with scientific bodies and we develop educational programs to constantly improve knowledge in advanced wound care.
- Leading with Science. We continually invest in R&D and deliver robust clinical evidence because we believe in evidence-based treatments.